Nuclear projects demand precision, trust, and proven expertise. Element supports utilities, manufacturers, and engineering teams with testing and qualification services that keep systems safe, compliant, and ready to perform—delivering data-driven insight to meet regulations and extend asset life.

Learn More

2020 ANS Virtual Winter Meeting: Medical isotopes production and applications

November 16, 2020, 5:28PMNuclear News

The Monday session “Advancement in Medical Isotopes Production and Applications” of the 2020 ANS Virtual Winter Meeting was sponsored by the Isotopes & Radiation Division and co-chaired by Lin-Wen Hu of Massachusetts Institute of Technology and James Bowen of Pacific Northwest National Laboratory.

Radioisotopes produced from nuclear reactors and accelerators are widely used for medical diagnostics and cancer therapy. Technetium-99m (decay product of molybdenum-99), for example, is used in more than 80 percent of nuclear medicine diagnostic procedures. The session featured speakers who discussed the advancement and status of domestic production and applications of medical isotopes.

To continue reading, log in or create a free account!

Related Articles

OSTP memo guides space nuclear plan

April 16, 2026, 12:00PMNuclear News

A White House Office of Science and Technology Policy (OSTP) memorandum released on Tuesday guides NASA, the Department of Energy, and the Department of Defense on their roles in deploying...

NRIC’s DOME “open for business”

April 10, 2026, 2:03PMNuclear News

On Wednesday, Idaho National Laboratory announced that the National Reactor Innovation Center’s Demonstration of Microreactor Experiments (DOME) test bed is now “open for business.” With...